Disitamab Vedotin

disitamab vedotin · Jiangsu Hengrui Medicine Co., Ltd.

Drug timelines are a Plus or Pro feature.

52 regulatory and trial events tracked for Disitamab Vedotin, covering 2021-11-09 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer [Phase 1, Phase 2]